Westman Atelier, the prestige brand cofounded by makeup artist Gucci Westman, launched Suprême Bio-Complex Liquid Foundation at $69, introducing exosome technology to the complexion market. The formula combines skincare actives with color correction, positioning the product as a hybrid between traditional foundation and treatment.
Exosomes, derived from plant stem cells, function as delivery vehicles for beneficial ingredients. Westman Atelier infused the foundation with peptides, hyaluronic acid, and botanical extracts designed to improve skin texture and luminosity over time. The approach reflects a broader industry shift toward performance-driven makeup that treats skin rather than simply covering it.
The launch represents significant expansion for Westman Atelier's foundation category. The brand, which built its reputation on blush and complexion products, now competes directly with established players like Estée Lauder's Double Wear and Charlotte Tilbury's Hollywood Flawless Filter. The $69 price point situates it in the premium-prestige bracket, above mass-market foundations but below ultra-luxury offerings.
Westman's background as a makeup artist informs the product development. Her previous work with celebrities and editorial shoots shaped her understanding of coverage demands and skin compatibility. The Suprême Bio-Complex targets consumers seeking both aesthetic results and skincare benefits, a demographic that grew substantially post-pandemic.
The exosome angle differentiates Westman Atelier in a crowded market. While competitors incorporate similar ingredients like peptides and hyaluronic acid, the exosome delivery system provides a functional hook. Beauty brands increasingly leverage biotechnology to justify premium pricing and performance claims.
Distribution remains primarily digital and through Sephora, channels where Westman Atelier has built significant customer loyalty. The brand's direct-to-consumer strategy allows higher